Business2 min
Lightbridge stock falls 8.5% as nuclear fuel startup's losses widen to $20.4M
The pre-revenue nuclear fuel developer has $236.7 million in cash and no debt, but investors balked at faster spending and a long road to market.

Shares of Lightbridge Corp. slid 8.46% to $4.65 on Monday after the nuclear fuel developer reported a wider loss for the first nine months of 2026. The company lost $20.4 million, or $0.62 a share, up from $12.4 million a year earlier.
Why the jump? Lightbridge is spending more to turn an idea into a product. It is developing Lightbridge Fuel, an advanced nuclear fuel meant to squeeze more power from reactors while keeping safety features intact. The company has no sales yet, so its results show spending and technical progress rather than revenue.
The costs are climbing fast. Total operating expenses rose 76.6% to $25.6 million from $14.5 million. Research and development spending more than doubled to $12.6 million from $5.3 million, and general and administrative costs grew to $13.0 million from $9.2 million. The company pointed to more research, more staff and added infrastructure. Cash burn from operations rose to $13.2 million from $8.1 million.
The cushion is still thick. Lightbridge ended Sept. 30 with $236.7 million in cash and equivalents, up 17.3% from the end of 2025, and it carries no debt. Part of that cash came from selling stock: the company raised $48.9 million by selling 4.3 million shares through its at-the-market program in the nine months. About $91.4 million remains available under that $150 million program.
That matters for shareholders because selling more shares can dilute existing owners. Investors are watching how long the cash lasts against rising spending, especially with commercialization still years away. The stock now sits near the bottom of its 52-week range, and after-hours trading was flat.
Management called the quarter a major step forward, citing its selection for the Nuclear Energy Launch Pad INL program. It also said testing at Idaho National Laboratory is progressing and that it is moving toward a pilot manufacturing concept. The next big checkpoint: the company expects its first meaningful post-irradiation examination results in the first half of 2027.
For everyday investors, the takeaway is simple. Lightbridge has money and no debt, but it is a long-dated bet on technical results that have yet to arrive. Until then, the market will likely keep judging how fast it spends. Source: Investing.com.
FiledUnited StatesJapan


